Contact Information: CONTACT: Health Sciences Group, Inc. Investor Relations Frank Godleski IR Representative Email Contact:
Health Sciences Enters Into LOI With The Healing Center of Montana to Acquire Two Medical Marijuana Licenses
| Source: Health Sciences Group, Inc
INDIAN HARBOR BEACH, FL--(Marketwire - December 15, 2009) - Health Sciences Group, Inc.
(PINKSHEETS : HESG ) would like to announce that it has entered into a letter
of intent with The Healing Center of Montana to purchase two operating
licenses for medical marijuana collectives in Park County, Montana and Lake
County, Montana. This transaction is contingent with standard due
diligence and anticipated to finalize before the end of the year.
The Healing Center of Montana, owned and operated by Mike Smith, is the
largest medical marijuana operation in the State of Montana and also has a
presence in Colorado. Mike Smith has been in the Montana medical marijuana
business since the state went legal.
"We anticipate this transaction to move very quickly, by the end of the
month if not sooner. Contracts and agreements are going back and forth
between the companies right now," stated Thomas Gaffney, CEO of Health
Sciences Group, Inc.
Gaffney continues, "Health Sciences Group intends on being the first public
medical marijuana company to derive actual revenues from medical marijuana
operations. Although The Healing Center is non-profit, these two new
locations would be for profit under a management agreement."
Montana, unlike California, allows collectives to be for profit.
ABOUT HEALTH SCIENCES GROUP, INC.
Health Sciences Group, Inc. is a provider of health and wellness services
to consumers, physicians and other healthcare professionals through its
website, www.igohealthy.org, and health focused publications. The Health
Sciences network consists of its public website, www.igohealthy.org, and
iGoHealthy Magazine. The Company operates in three segments: Online
Services, Publishing and Other Services. The Company is recently exploring
options of corporate growth within the Legal Medical Marijuana Industry.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and
information, as defined within the meaning of Section 27A of the Securities
Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is
subject to the Safe Harbor created by those sections. This material
contains statements about expected future events and/or financial results
that are forward-looking in nature and subject to risks and uncertainties.
Such forward-looking statements by definition involve risks, uncertainties
and other factors, which may cause the actual results, performance or
achievements of Health Sciences Group, Inc. to be materially different from
the statements made herein. Investors are highly advised to seek
professional advice and conduct a complete due diligence regarding this, or
any other company being considered for investment purposes. Investing in
securities, particularly in issues priced at less than $1 per share,
involves substantial risk and may result in a partial or complete loss of
investment capital. Health Sciences Group, Inc., its subsidiaries,
officers and employees cannot guarantee the completeness or accuracy of the
information contained in company press releases or other company
communications. Press releases and communications issued by the company
should not be interpreted as an offer to sell or a solicitation to buy
company stock.
Investors are highly advised to seek professional advice and conduct a
complete due diligence regarding this, or any other company being
considered for investment purposes. Investing in securities, particularly
in issues priced at less than $1 per share, involves substantial risk and
may result in a partial or complete loss of investment capital. Health
Sciences Group, Inc., its subsidiaries, officers and employees cannot
guarantee the completeness or accuracy of the information contained in
company press releases or other company communications. Press releases and
communications issued by the company should not be interpreted as an offer
to sell or a solicitation to buy company stock.